New genetic insights in familial hyperaldosteronism

Annals of the New York Academy of Sciences

Volumn 970, Issue , 2002, Pages 77-88

  Jackson, Richard V ^a   Lafferty, Anthony ^a   Torpy, David J ^a   Stratakis, Constantine ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

Diagnosis; Familial; FH II; Genetics; Glucocorticoid remediable hyperaldosteronism; Primary aldosteronism

Indexed keywords

ALDOSTERONE; ALDOSTERONE SYNTHASE; ANGIOTENSIN 2 RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CORTICOTROPIN; DEXAMETHASONE; DIHYDROPYRIDINE DERIVATIVE; DIURETIC AGENT; FLUDROCORTISONE; GLUCOCORTICOID; MINERALOCORTICOID; POTASSIUM; RENIN; SODIUM CHLORIDE; SPIRONOLACTONE; STEROID 11BETA MONOOXYGENASE;

ADRENALECTOMY; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; AUTOSOMAL DOMINANT DISORDER; BLOOD VOLUME; CHROMOSOME 7P; CONFERENCE PAPER; CROSSING OVER; DEXAMETHASONE SUPPRESSION TEST; DISEASE CLASSIFICATION; FAMILIAL DISEASE; FAMILIAL HYPERALDOSTERONISM 1; FAMILIAL HYPERALDOSTERONISM 2; GENE MUTATION; GENETIC LINKAGE; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOKALEMIA; MARKER GENE; PLASMA RENIN ACTIVITY; POTASSIUM BLOOD LEVEL; PRIMARY HYPERALDOSTERONISM; SCREENING TEST; ZONA GLOMERULOSA;

EID: 0037024520     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2002.tb04414.x     Document Type: Conference Paper

References (64)

1. Mornet, E., J. Dupont, A. Vitek, et al. 1989. Characterisation of the two genes encoding human steroid 11β-hydroxylase (P-450 (11)β). J. Biol. Chem. 264: 20961-20967.
2. Curnow, K.M., M.T. Tusle-Luna, L. Pascoe, et al. 1991. The product of the CYP11B2 gene is required for aldosterone biosynthesis in the human adrenal cortex. Mol. Endocrinol. 5: 1513-1522.
3. Taymans, S.E., S. Pack, E. Pak, et al. 1998. Human CYP11B2 (aldosterone synthase) maps to chromosome 8q24.3. J. Clin. Endocrinol. Metab. 83: 1033-1036.
4. McKenna, T.J., D.P. Island, W.E. Nicholson, et al. 1978. The effect of potassium on early and late steps in aldosterone biosynthesis in cells of the zona glomerulosa. Endocrinology 103: 141.
5. Clyne, C.D., Y. Zhang, L. Slutsker, et al. 1997. Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements. Mol. Endocrinol. 11: 638-649.
6. Brown, J.J., D.L. Davies & A.F. Lever. 1964. Variations in plasma renin concentration in several physiological and pathological states. Can. Med. Assoc. J. 90: 201.
7. Gaillard, R.C., A.M. Riondel, C.A. Farrod-Coune, et al. 1983. Aldosterone escape to chronic ACTH administration in man. Acta Endocrinol. (Copenh.) 103: 116.
8. Blair-West, J.R., J.P. Coughlin & D.A. Denton. 1980. A dose response comparison of the actions of angiotensin II and III in sheep. J. Endocrinol. 87: 409.
9. Carey, R.M. 1982. Acute dopaminergic inhibition of aldosterone secretion is independent of angiotensin II and adrenococrticotropin. J. Clin. Endocrinol. Metab. 54: 463-469.
10. Sheppard, K.E. & J.W. Funder. 1987. Equivalent affinity of aldosterone and corticosterone for type I receptors in kidney and hippocampus: Direct binding studies. J. Steroid Biochem. 28: 737.
11. Sheppard, K.E. & J.W. Funder. 1987. Type I receptors in parotid, colon, and pituitary and aldosterone selective in vivo. Am. J. Physiol. 253: E467.
12. Funder, J.W. 1995. Apparent mineralocorticoid excess. Endocrinol. Metab. Clin. N. Amer. 24: 613-621.
13. Campbell, S.E., A.A. Diaz-Arias & K.T. Weber. 1992. Fibrosis of the human heart and systemic organs in adrenal adenoma. Blood Pres. 1: 149-156.
14. Sun, Y., F.J. Ramires & K.T. Weber. 1997. Fibrosis of atria and great vessels in response to angiotensin II or aldosterone infusion. Cardiovasc. Res. 35: 138-147.
15. Robert, V., C. Heymes & J.S. Silvestre. 1999. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: Role in aldosterone-salt-induced fibrosis. Hypertension 33: 981-986.
16. Conn, J.W. 1995. Primary aldosteronism, a new clinical syndrome. J. Lab. Clin. Med. 45: 3-17.
17. Conn, J.W., R.F. Knopf & R.M. Nesbit. 1964. Clinical characteristics of primary aldosteronism from an analysis of 145 cases. Am. J. Surg. 107: 159-172.
18. Kaplan, N.M. 1992. Endocrine hypertension. In Williams Textbook of Endocrinology, 8th ed. :707-731. W.B. Saunders. Philadelphia.
19. Streeten, D.H.P., N. Tomycz & G.H. Anderson, Jr. 1979. Reliability of screening methods for the diagnosis of primary aldosteronism. Am. J. Med. 67: 403-413.
20. Gordon, R.D., M. Stowasser, T.J. Tunny, et al. 1994. High incidence of primary hyperaldosteronism in 199 patients referred with hypertension. Clin. Exp. Pharmacol. Physiol. 21: 315-418.
21. Gordon, R.D. 1995. Primary aldosteronism. J. Endocrinol. Invest. 18: 495-511.
22. Fardella, C.E., L. Mosso, C.E. Gomez-Sanchez, et al. 2000. Primary hyperaldosteronism in essential hypertensives: Prevalence, biochemical profile and molecular biology. J. Clin. Endocrinol. Metab. 85: 1863-1867.
23. Lim, P.W., E. Dow, G. Brennan, et al. 2000. High prevalence of primary aldosteronism in the Tayside Hypertension Clinic population. J. Hum. Hypertens. 14: 311-315.
24. Loh, K.C., E.S. Koay, M.C. Khaw, et al. 2000. Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J. Clin. Endocrinol. Metab. 85: 2854-2859.
25. Nishikawa, T. & M. Omura. 2000. Clinical characteristics of primary aldosteronism: Its prevalence and comparative studies on various causes of primary aldosteronism in Yokohama Rosai Hospital. Biomed. Pharmacother. 54(Suppl 1): 83s-85s.
26. Weisnagel, S.J., M. Gagner, G. Breton, et al. 1996. Laparoscopic adrenalectomy. The Endocrinologist 6: 169-178.
27. Litchfield, W.R. & R.G. Dluhy. 1995. Primary aldosteronism. Endocrinol. Metab. Clin. N. Amer. 24: 593-612.
28. Hiramatsu, K., T. Yamada, Y. Yukimura, et al. 1981. A screeening test to identify aldosterone-producing adenoma by measuring plasma renin activity: Results in hypertensive patients. Arch. Intern. Med. 141: 1589-1593.
29. McKenna, T.J., S.J. Sequeira, A. Heffernan, et al. 1991. Diagnosis under random conditions of all disorders of the renin-angiotensin.-aldosterone axis, including primary hyperaldosteronism. J. Clin. Endocrinol. Metab. 73: 952-957.
30. Ignatowska-Switalska, H., J. Chodakowska, W. Januszewicz, et al. 1997. Evaluation of plasma aldosterone to plasma renin activity ratio in patients with primary aldosteronism. J. Hum. Hypertens. 11: 373-378.
31. Montori, V.M., G.L. Schwartz, A.B. Chapman, et al. 2001. Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin. Proc. 76: 877-882.
32. Kaplan, N.M. 2001. Caution about the overdiagnosis of primary aldosteronism. Mayo Clin. Proc. 76: 875-876.
33. Melby, J.C. 1991. Diagnosis of hyperalodsteronism. Endocrinol. Metab. Clin. N. Amer. 20: 247-255.
34. Bravo, E.L., R.C. Turazi & H.P Dustan. 1983. The changing clinical spectrum of primary aldosteronism. Am. J. Med. 74: 641-651.
35. Hambling, C., R.T. Jung, A. Gunn, et al. 1992. Re-evaluation of the captopril test for the diagnosis of primary hyperaldosteronism. Clin. Endocrinol. (Oxf.) 36: 499-503
36. Iwaoka, T., T. Umeda, S. Naomi, et al. 1993. The usefulness of the captopril test as a simultaneous screening for primary aldosteronism and renovascular hypertension. Am. J. Hypertens. 6: 899-906.
37. Ganguly, A. 2001. Prevalence of primary aldosteronism in unselected hypertensive populations: Screening and definitive diagnosis. J. Clin. Endocrinol. Metab. 86: 4002-4003.
38. Young, W.F., Jr. & G.G. Klee. 1988. Primary aldosteronism: Diagnostic evaluation. Endocrinol. Metab. Clin. N. Amer. 17: 367-395.
39. Ulick, S., J.D. Blumenfield, S.A. Atlas, et al. 1993. The unique steroidogenesis of the aldosteronoma in the differential diagnosis of primary aldosteronism. J. Clin. Endocrinol. Metab. 76: 873-878.
40. Doppman, J.L. & J.R. Gill, Jr. 1996. Hyperaldosteronism: Sampling the adrenal veins. Radiology 198: 309-312.
41. Young, W.F., Jr. 1997. Primary hyperaldosteronism: Update on diagnosis and treatment. The Endocrinologist 7: 213-221.
42. Phillips, J.L., M.M. Walther, J.C. Pezzullo, et al. 2000. Predictive value of preoperative tests in discriminating bilateral adrenal hyperplasia from an aldosterone-producing adrenal adenoma. J. Clin. Endocrinol. Metab. 85: 4526-4533.
43. Magill, S.B., H. Raff, J.L. Shaker, et al. 2001. Comparison of adrenal vein sampling and computed tomography in the differentiation of primary aldosteronism. J. Clin. Endocrinol. Metab. 86: 1066-1071.
44. Rossi, G.P., A. Sacchetto, M. Chiesura-Corona, et al. 2001. Identification of the etiology of primary aldosteronism with adrenal vein sampling in patients with equivocal computed tomography and magnetic resonance findings: Results in 104 consecutive cases. J. Clin. Endocrinol. Metab. 86: 1083-1090.
45. Biglieri, E.G. 1997. Primary aldosteronism. Curr. Ther. Endocrinol. Metab. 6: 170-172.
46. Beckers, A., R. Abs & P.J. Willems. 1992. Aldosterone secreting adenoma as part of multiple endocrine neoplasia type 1 (MEN I): Loss of heterozygosity for polymorphic chromosome 11 deoxyribonucleic acid markers, including the MEN I locus. J. Clin. Endocrinol. Metab. 75: 564-570.
47. Sutherland, D.J.A., J.C. Ruse & J.C. Laidlaw. 1966. Hypertension increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. J. Can. Med. Assoc. 95:1109-1119.
48. Pascoe, L., X. Jeunemaitre, M.C. Lebrethon, et al. 1995. Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J. Clin. Invest. 96: 2236-2246.
49. Lifton, R.P., R.G. Dluhy, M. Powers, et al. 1992. A chimaeric 11β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355: 262-265.
50. Ulick, S. & M.D. Chu. 1982. Hypersecretion of a new corticosteroid, 18-hydroxycortisol in two types of adrenocortical hypertension. Clin. Exp. Hypertens. A4: 1771-1777.
51. Jamieson, A., L. Slutsker, G.C. Inglis, et al. 1995. Glucocorticoid suppressible hyperaldosteronism: Effects of cross-over site and parental origin of chimaeric gene on phenotypic expression. Clin. Sci. 88: 563-570.
52. White, P.C. 1997. Abnormalities of aldosterone synthesis and action in children. Curr. Opin. Pediatr. 9: 424-430.
53. Gates, L.J., A.A. MacConnachie, R.P. LIFTON, et al. 1996. Variation of phenotype in patients with GRA. J. Med. Genet. 33: 25-28.
54. Litchfield, W.R,. M.I. New, C. Coolidge, et al. 1997. Evaluation of the dexamethasone suppression test for the diagnosis of glucocorticoid-remediable aldosteronism. J. Clin. Endocrinol. Metab. 82: 3570-3573.
55. Litchfield, W.R., B.F. Anderson, R.J. Weiss, et al. 1998. Intracranial aneurysm and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31: 445-450.
56. Torpy, D.J., R.D. Gordon, J.-P. Lin, et al. 1998. Familial hyperaldosteronism type-II: Description of a large kindred and exclusion of the aldosterone synthane (CYP11B2) gene. J. Clin. Endocrinol. Metab. 83: 3214-3218.
57. London, N., J. Swales, K. Hollinrake, et al. 1992. Familial Conn's syndrome. Postgrad. Med. J. 68: 976-977.
58. Greco, R.G., J.E. Carroll, D.J. Morris, et al. 1982. Familial hyperaldosteronism, not suppressed by dexamethasone. J. Clin. Endocrinol. Metab. 55: 1013-1016.
59. Gordon, R.D. & M. Stowasser. 1998. Familial forms broaden the horizons for primary aldosteronism. Trends Endocrinol. Metab. 9: 220-227.
60. Torpy, D.J., R.D. Gordon & C.A. Stratakis. 1998. Linkage analysis of familial hyperaldosteronism type II: Absence of linkage to the gene encoding the angiotensin II receptor type 1. J. Clin. Endocrinol. Metab. 83:1046.
61. Jonsson, J.R., S.A. Klemm, T.J. Tunny, et al. 1995. A new genetic test for familial hyperaldosteronism type 1 aids in the detection of curable hypertension. Biochem. Biophys. Res. Commun. 207: 565-571.
62. Katoh, T., T. Ise, H. Takakuwa, et al. A new variant of familial hyperaldosteronism [abstract P1813]. Proceedings of the 14th International Congress on Nephrology, 1997.
63. Lafferty, A.R., D.J. Torpy, M. Stowasser, et al. 2000. A novel genetic locus for low renin hypertension: Familial hyperaldosteronism type II maps to chromosome 7 (7p22). J. Med. Genet. 37: 831-835.
64. Kirschner, L.S., J.A. Carney, S. Pack, et al. 2000. Mutations of the PRKAR1A gene in patients with Carney complex. Nat. Genet. 26: 89-92.